Cargando…
Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) patt...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313428/ https://www.ncbi.nlm.nih.gov/pubmed/28050003 |
_version_ | 1782508341522595840 |
---|---|
author | Yokohori, Naoko Sato, Akitoshi Hasegawa, Mizue Katsura, Hideki Hiroshima, Kenzo Takemura, Tamiko |
author_facet | Yokohori, Naoko Sato, Akitoshi Hasegawa, Mizue Katsura, Hideki Hiroshima, Kenzo Takemura, Tamiko |
author_sort | Yokohori, Naoko |
collection | PubMed |
description | Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) pattern or idiopathic interstitial pneumonia (IIP) pattern. Treatments for HABA include corticosteroids for the IIP pattern and erythromycin for the DPB pattern. We herein report a case of HABA-associated unclassifiable interstitial pneumonia that improved with combined therapy with pirfenidone and erythromycin. This is the first report on the effectiveness of combined therapy with pirfenidone and erythromycin for HABA. |
format | Online Article Text |
id | pubmed-5313428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-53134282017-02-28 Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) Yokohori, Naoko Sato, Akitoshi Hasegawa, Mizue Katsura, Hideki Hiroshima, Kenzo Takemura, Tamiko Intern Med Case Report Human T-cell lymphotropic virus type 1 (HTLV-1) is a retrovirus involved in the pathogenesis of adult T-cell leukemia (ATL) and HTVL-1-associated bronchioloalveolar disorder (HABA). The clinical and pathological findings of HABA have been characterized as either a diffuse panbronchiolitis (DPB) pattern or idiopathic interstitial pneumonia (IIP) pattern. Treatments for HABA include corticosteroids for the IIP pattern and erythromycin for the DPB pattern. We herein report a case of HABA-associated unclassifiable interstitial pneumonia that improved with combined therapy with pirfenidone and erythromycin. This is the first report on the effectiveness of combined therapy with pirfenidone and erythromycin for HABA. The Japanese Society of Internal Medicine 2017-01-01 /pmc/articles/PMC5313428/ /pubmed/28050003 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Yokohori, Naoko Sato, Akitoshi Hasegawa, Mizue Katsura, Hideki Hiroshima, Kenzo Takemura, Tamiko Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title | Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title_full | Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title_fullStr | Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title_full_unstemmed | Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title_short | Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA) |
title_sort | effectiveness of combined therapy with pirfenidone and erythromycin for unclassifiable interstitial pneumonia induced by htlv-1-associated bronchioloalveolar disorder (haba) |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313428/ https://www.ncbi.nlm.nih.gov/pubmed/28050003 |
work_keys_str_mv | AT yokohorinaoko effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba AT satoakitoshi effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba AT hasegawamizue effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba AT katsurahideki effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba AT hiroshimakenzo effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba AT takemuratamiko effectivenessofcombinedtherapywithpirfenidoneanderythromycinforunclassifiableinterstitialpneumoniainducedbyhtlv1associatedbronchioloalveolardisorderhaba |